Logo image of LUCY

INNOVATIVE EYEWEAR INC (LUCY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:LUCY - US45791D2080 - Common Stock

1.68 USD
+0.04 (+2.44%)
Last: 1/13/2026, 8:00:00 PM
1.64 USD
-0.04 (-2.38%)
After Hours: 1/13/2026, 8:00:00 PM
Fundamental Rating

4

LUCY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While LUCY has a great health rating, there are worries on its profitability. LUCY shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year LUCY has reported negative net income.
  • LUCY had a negative operating cash flow in the past year.
  • LUCY had negative earnings in each of the past 5 years.
  • In the past 5 years LUCY always reported negative operating cash flow.
LUCY Yearly Net Income VS EBIT VS OCF VS FCFLUCY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • LUCY has a Return On Assets of -70.22%. This is in the lower half of the industry: LUCY underperforms 72.97% of its industry peers.
  • LUCY has a Return On Equity of -76.56%. This is comparable to the rest of the industry: LUCY outperforms 41.08% of its industry peers.
Industry RankSector Rank
ROA -70.22%
ROE -76.56%
ROIC N/A
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LUCY Yearly ROA, ROE, ROICLUCY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

  • LUCY's Gross Margin of 22.83% is on the low side compared to the rest of the industry. LUCY is outperformed by 78.92% of its industry peers.
  • In the last couple of years the Gross Margin of LUCY has declined.
  • The Profit Margin and Operating Margin are not available for LUCY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
LUCY Yearly Profit, Operating, Gross MarginsLUCY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

7

2. Health

2.1 Basic Checks

  • LUCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LUCY has been increased compared to 1 year ago.
  • LUCY has less shares outstanding than it did 5 years ago.
  • LUCY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LUCY Yearly Shares OutstandingLUCY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M
LUCY Yearly Total Debt VS Total AssetsLUCY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • Based on the Altman-Z score of 0.86, we must say that LUCY is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.86, LUCY perfoms like the industry average, outperforming 48.65% of the companies in the same industry.
  • There is no outstanding debt for LUCY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACC9.95%
LUCY Yearly LT Debt VS Equity VS FCFLUCY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 11.98 indicates that LUCY has no problem at all paying its short term obligations.
  • The Current ratio of LUCY (11.98) is better than 94.59% of its industry peers.
  • LUCY has a Quick Ratio of 10.13. This indicates that LUCY is financially healthy and has no problem in meeting its short term obligations.
  • LUCY's Quick ratio of 10.13 is amongst the best of the industry. LUCY outperforms 94.05% of its industry peers.
Industry RankSector Rank
Current Ratio 11.98
Quick Ratio 10.13
LUCY Yearly Current Assets VS Current LiabilitesLUCY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

8

3. Growth

3.1 Past

  • LUCY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.66%, which is quite impressive.
  • Looking at the last year, LUCY shows a very strong growth in Revenue. The Revenue has grown by 53.21%.
  • Measured over the past years, LUCY shows a very strong growth in Revenue. The Revenue has been growing by 33.36% on average per year.
EPS 1Y (TTM)72.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.62%
Revenue 1Y (TTM)53.21%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%163.46%

3.2 Future

  • The Earnings Per Share is expected to grow by 36.67% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 117.64% on average over the next years. This is a very strong growth
EPS Next Y71.92%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.63%
Revenue Next 2Y117.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LUCY Yearly Revenue VS EstimatesLUCY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M
LUCY Yearly EPS VS EstimatesLUCY Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LUCY. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LUCY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LUCY Price Earnings VS Forward Price EarningsLUCY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LUCY Per share dataLUCY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • LUCY's earnings are expected to grow with 36.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.67%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • LUCY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

INNOVATIVE EYEWEAR INC

NASDAQ:LUCY (1/13/2026, 8:00:00 PM)

After market: 1.64 -0.04 (-2.38%)

1.68

+0.04 (+2.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners6.95%
Inst Owner Change0%
Ins Owners15.63%
Ins Owner Change-16.73%
Market Cap8.99M
Revenue(TTM)2.39M
Net Income(TTM)-7.85M
Analysts82.86
Price Target3.06 (82.14%)
Short Float %5.53%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.97%
Min EPS beat(2)15.97%
Max EPS beat(2)23.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.87%
Min Revenue beat(2)-43.24%
Max Revenue beat(2)-34.5%
Revenue beat(4)0
Avg Revenue beat(4)-41.35%
Min Revenue beat(4)-55.39%
Max Revenue beat(4)-32.28%
Revenue beat(8)1
Avg Revenue beat(8)-18.57%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-40%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.42%
EPS NY rev (1m)0%
EPS NY rev (3m)6.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-65.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-27.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.76
P/FCF N/A
P/OCF N/A
P/B 0.88
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)-2.63
EYN/A
EPS(NY)-1.05
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.47
OCFYN/A
SpS0.45
BVpS1.92
TBVpS1.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.22%
ROE -76.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.83%
FCFM N/A
ROA(3y)-102.4%
ROA(5y)-213.8%
ROE(3y)-115.52%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.43%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.89%
Cap/Sales 5.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.98
Quick Ratio 10.13
Altman-Z 0.86
F-Score3
WACC9.95%
ROIC/WACCN/A
Cap/Depr(3y)402.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)23.82%
Cap/Sales(5y)37.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.62%
EPS Next Y71.92%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.21%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%163.46%
Revenue Next Year52.63%
Revenue Next 2Y117.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-29.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.43%
OCF growth 3YN/A
OCF growth 5YN/A

INNOVATIVE EYEWEAR INC / LUCY FAQ

Can you provide the ChartMill fundamental rating for INNOVATIVE EYEWEAR INC?

ChartMill assigns a fundamental rating of 4 / 10 to LUCY.


Can you provide the valuation status for INNOVATIVE EYEWEAR INC?

ChartMill assigns a valuation rating of 1 / 10 to INNOVATIVE EYEWEAR INC (LUCY). This can be considered as Overvalued.


What is the profitability of LUCY stock?

INNOVATIVE EYEWEAR INC (LUCY) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for LUCY stock?

The Earnings per Share (EPS) of INNOVATIVE EYEWEAR INC (LUCY) is expected to grow by 71.92% in the next year.